NO20042380L - Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider - Google Patents

Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider

Info

Publication number
NO20042380L
NO20042380L NO20042380A NO20042380A NO20042380L NO 20042380 L NO20042380 L NO 20042380L NO 20042380 A NO20042380 A NO 20042380A NO 20042380 A NO20042380 A NO 20042380A NO 20042380 L NO20042380 L NO 20042380L
Authority
NO
Norway
Prior art keywords
polypeptides
factor
pharmaceutical preparation
factor vii
vii polypeptides
Prior art date
Application number
NO20042380A
Other languages
English (en)
Inventor
Rasmus Rojkjaer
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of NO20042380L publication Critical patent/NO20042380L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20042380A 2001-11-09 2004-06-08 Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider NO20042380L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101660 2001-11-09
PCT/DK2002/000736 WO2003039584A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides

Publications (1)

Publication Number Publication Date
NO20042380L true NO20042380L (no) 2004-06-08

Family

ID=8160820

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042380A NO20042380L (no) 2001-11-09 2004-06-08 Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider

Country Status (16)

Country Link
EP (1) EP1446149A1 (no)
JP (1) JP2005511599A (no)
KR (1) KR20050043734A (no)
CN (1) CN1596125A (no)
AU (1) AU2002340779B2 (no)
BR (1) BR0213953A (no)
CA (1) CA2464615A1 (no)
CZ (1) CZ2004543A3 (no)
HU (1) HUP0401985A3 (no)
IL (1) IL161544A0 (no)
MX (1) MXPA04004304A (no)
NO (1) NO20042380L (no)
PL (1) PL370634A1 (no)
RU (1) RU2004117534A (no)
WO (1) WO2003039584A1 (no)
ZA (1) ZA200403271B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ200240A3 (cs) 1999-07-14 2003-04-16 Novo Nordisk A/S Léčivo s obsahem agonisty nebo antagonisty tkáňového faktoru pro regulaci buněčné migrace
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
BRPI0507156A (pt) * 2004-02-05 2007-06-26 Novo Nordisk Healthcare Ag uso de fator viia ou de um equivalente de fator viia, kit de partes e método para prevenir ou atenuar uma ou mais complicações tardias de trauma, e, métodos para reduzir o número de dias em que um paciente de trauma é hospitalizado após trauma, para reduzir o número de dias que um paciente de trauma passa em uma unidade de tratamento intensivo após trauma, para melhorar função pulmonar em um paciente de trauma, para reduzir o risco de desenvolver lesão pulmonar aguda e/ou sìndrome do sofrimento respiratório agudo em um paciente de trauma, para reduzir o risco de desenvolver coagulação intravascular disseminada em um paciente de trauma, para reduzir o risco de desenvolver sìndrome da resposta inflamatória sistêmica em um paciente de trauma, para reduzir o risco de desenvolver falha de órgãos múltiplos em um paciente de trauma, para reduzir o risco de morte em um paciente de trauma e para prevenir ou atenuar uma ou mais complicações tardias de trauma
FR2894831B1 (fr) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
US8461115B2 (en) 2006-03-16 2013-06-11 Stellaris Pharmaceuticals Aps Methods for local treatment with factor VII
CN105848668A (zh) * 2013-11-04 2016-08-10 加利福尼亚大学董事会 治疗或预防与出血或低凝血相关联的病状的疗法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE200225T1 (de) * 1994-04-22 2001-04-15 Sanquin Bloedvoorziening Mittel für die behandlung von störungen des blutgerinnungsprozess
AU7907398A (en) * 1997-06-23 1999-01-04 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
WO1999058699A2 (en) * 1998-05-14 1999-11-18 Battelle Memorial Institute Transgenic plant-derived human blood coagulation factors

Also Published As

Publication number Publication date
PL370634A1 (en) 2005-05-30
CA2464615A1 (en) 2003-05-15
BR0213953A (pt) 2004-08-31
EP1446149A1 (en) 2004-08-18
WO2003039584A1 (en) 2003-05-15
HUP0401985A3 (en) 2009-03-30
AU2002340779B2 (en) 2007-08-02
JP2005511599A (ja) 2005-04-28
HUP0401985A2 (hu) 2004-12-28
MXPA04004304A (es) 2004-08-11
ZA200403271B (en) 2004-11-08
KR20050043734A (ko) 2005-05-11
CZ2004543A3 (cs) 2004-08-18
RU2004117534A (ru) 2005-05-10
IL161544A0 (en) 2004-09-27
CN1596125A (zh) 2005-03-16

Similar Documents

Publication Publication Date Title
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20033143D0 (no) Farmasoytisk preparat
NO20033556D0 (no) Farmasöytiske preparater
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
HUP0500989A2 (en) Animicrobial polypeptides and their uses
NO20033785L (no) Farmasöytisk formulering
DK200300344U1 (da) Amlodipinmaleat og farmaceutisk præparat indeholdende amlodipinmaleat
NO20034159D0 (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
IS7089A (is) Lyfjasamsetningar amlódipíns og atórvastatíns
NO20035627D0 (no) Farmasöytisk formulering
NO20025805D0 (no) Farmasöytisk preparat
NO20040235L (no) Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider
IL159872A0 (en) Gmg-2 polypeptides and their use
EP1462455A4 (en) NOVEL PEPTIDES AND THEIR USES AS MEDICAMENTS
NO20042693L (no) Kateterpreparat og anvendelser derav
NO20023144D0 (no) Kompleks omfattende OCIF og polysakkarid
NO20042380L (no) Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider
NO20042379L (no) Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider
NO20015534D0 (no) Farmasöytisk blandeapparat
NO20021036D0 (no) Farmasöytisk preparat
DE60219418D1 (de) Silanylphenole und -naphthole
DK200100256U3 (da) Amlodipinmaleat og farmaceutiske præparater indeholdende dette
NO20041236L (no) Farmasoytisk formulering
GB0109558D0 (en) Polypeptides and their uses

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application